tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Novartis (DE:NOT)
XETRA:NOT
Germany Market
NOT
Novartis AG
Overview
Analyst Forecasts
Dividends
Earnings
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
Drug Pipeline
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Novartis AG (NOT) Stock News & Sentiment

Compare
24 Followers
Novartis AG Faces Sell Rating Amid Overvaluation and Looming Generic Competition
Premium
Ratings
Novartis AG Faces Sell Rating Amid Overvaluation and Looming Generic Competition
6d ago
NVS
Novartis AG: Balancing Promising Pipeline Developments with Valuation and Risk Concerns
Premium
Ratings
Novartis AG: Balancing Promising Pipeline Developments with Valuation and Risk Concerns
14d ago
NVS
Exelixis and Novartis: Key Updates from the Pan Tumor Rollover Study
Premium
Company Announcements
Exelixis and Novartis: Key Updates from the Pan Tumor Rollover Study
22d ago
EXEL
Novartis and Incyte’s Ruxolitinib Study: A Potential Game-Changer for Myelofibrosis Treatment
Premium
Company Announcements
Novartis and Incyte’s Ruxolitinib Study: A Potential Game-Changer for Myelofibrosis Treatment
27d ago
NVS
Pan-Tumor Rollover Study: A New Horizon in Long-term Cancer Treatment
Premium
Company Announcements
Pan-Tumor Rollover Study: A New Horizon in Long-term Cancer Treatment
1M ago
BMY
NVS
Novartis and Olema’s Phase 1b Breast Cancer Study: Market Watch
Premium
Company Announcements
Novartis and Olema’s Phase 1b Breast Cancer Study: Market Watch
1M ago
NVS
Novartis AG: Balancing Promising Drug Developments with Market Challenges – Hold Recommendation
Premium
Ratings
Novartis AG: Balancing Promising Drug Developments with Market Challenges – Hold Recommendation
1M ago
NVS
More DE:NOT News >

NOT News on the Web

Novartis (NVS) was downgraded to a Sell Rating at Goldman Sachs
TipRanks News
Neutral
Morgan Stanley Sticks to Its Hold Rating for Novartis AG (NOVN)
TipRanks News
Neutral
UBS Remains a Hold on Novartis AG (NOVN)
TipRanks News
Neutral
Deutsche Bank Remains a Buy on Novartis AG (NOVN)
TipRanks News
Neutral
UBS Sticks to Its Hold Rating for Novartis AG (NOVN)
TipRanks News
Neutral
Deutsche Bank Reaffirms Their Buy Rating on Novartis AG (NOVN)
TipRanks News
Neutral
UBS Sticks to Its Hold Rating for Novartis AG (NOVN)
TipRanks News
Neutral
Deutsche Bank Keeps Their Buy Rating on Novartis AG (NOVN)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
DE:NOT
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:NOT’s Media Buzz Sentiment?
1 articles about DE:NOT were published this week. In an average week, 1 articles are published.
    What is DE:NOT’s weekly average amount of articles?
    In an average week, 1 articles about DE:NOT are published.
      What is DE:NOT’s News Sentiment?
      50% of articles about DE:NOT were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        GLUEMonte Rosa Therapeutics
        PODDInsulet
        LHLabcorp Holdings
        THCTenet Healthcare
        CHEKCheck-Cap
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing